KMTS

Kestra Medical Technologies, Ltd. Common Stock

KMTS.US kestramedical.com
23.57
-0.50 (-2.08%)
USD · NASDAQ
52-week range
17.34
30.00
Trading at 49% of the 52-week range
Market Cap
1.41B
P/E Ratio
0.00
Forward P/E
0.00
Book Value
4.45
Div. Yield
N/A
% Institutions
103.20%
% Insiders
5.30%

1 Year

+29.6%

3 Year

+7.9%

10 Year

+7.9%
Description

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.

Company Information

Company Name
Kestra Medical Technologies, Ltd. Common Stock
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
ISIN: BMG524411052
Currency: USD
Full Time Employees: 443
Phone: 425 279 8002
Fiscal Year End: April
IPO Date: Mar 06, 2025
Description:

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.

Address:

3933 Lake Washington Blvd NE, Kirkland, WA, United States, 98033

People

Directors & Officers

Name Title Year Born
Mr. Brian Webster Founder, President, CEO & Director 1964
Ms. Traci S. Umberger Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director 1963
Mr. Vaseem Mahboob Chief Financial Officer 1969
Mr. Gordon Teddy Chief Information Officer NA
Mr. Alfred J. Ford Jr. Chief Commercial Officer 1971
Mr. Neil Bhalodkar Vice President of Investor Relations NA
Ms. Debra Schotz Senior Vice President of Marketing 1970
Mr. Jeffrey Laub Senior Vice President of Operations 1971
Mr. Timothy P. Moran Chief Business Officer 1972
Mr. R. Curtis Kopf Senior Vice President of Customer Experience 1966

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 15, 2026 Brian Daniel Webster N/A Sale 15.00K $20.04 $300.60K
Mar 17, 2026 Brian Daniel Webster N/A Sale 15.00K $20.27 $304.05K
Feb 17, 2026 Brian Daniel Webster N/A Sale 15.00K $25.60 $384.00K
Jan 15, 2026 Brian Daniel Webster N/A Sale 15.00K $22.80 $342.00K
Dec 29, 2025 Brian Daniel Webster N/A Sale 15.00K $26.59 $398.85K
Dec 29, 2025 Traci S Umberger N/A Sale 10.50K $26.69 $280.25K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Bain Capital Investors LLC 25.17M Jun 30, 2026 42.95% $13.30 0.00%
T. Rowe Price Associates, Inc. 5.97M Mar 31, 2026 10.18% $0.01 36.60%
FMR Inc 5.72M Mar 31, 2026 9.76% $0.01 -2.23%
Andera Partners 2.73M Jun 30, 2026 4.66% $33.62 1.24%
Yu Fan 2.28M Mar 31, 2026 3.89% $46.89 0.00%
Brown Advisory Holdings Inc 1.72M Mar 31, 2026 2.94% $0.06 2.10%
BlackRock Inc 1.69M Mar 31, 2026 2.88% $0.00 36.82%
Eventide Asset Management, LLC 1.45M Jun 30, 2026 2.47% $0.49 0.06%
AllianceBernstein L.P. 1.32M Mar 31, 2026 2.25% $0.01 -7.41%
Franklin Templeton Inc 1.24M Mar 31, 2026 2.12% $0.01 30.73%
Vanguard Capital Management, LLC 1.21M Mar 31, 2026 2.07% $0.00 0.00%
Omega Fund Management LLC 1.02M Mar 31, 2026 1.74% $12.49 -25.59%
State Street Corp 671.11K Mar 31, 2026 1.15% $0.00 53.87%
Hood River Capital Management LLC 655.88K Mar 31, 2026 1.12% $0.13 17.03%
Geode Capital Management, LLC 573.93K Mar 31, 2026 0.98% $0.00 36.94%
Federated Hermes Inc 525.00K Jun 30, 2026 0.90% $0.02 0.00%
Next Century Growth Investors LLC 458.51K Jun 30, 2026 0.78% $0.62 0.21%
Driehaus Capital Management LLC 447.32K Mar 31, 2026 0.76% $0.07 -3.40%
UBS Group AG 349.69K Mar 31, 2026 0.60% $0.00 29.49%
The Goldman Sachs Group Inc 288.35K Mar 31, 2026 0.49% $0.00 5.84%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 US Small-Cap Growth II Equity Comp 2.44M 4.17% ▼ 5.71% Jun 30, 2026
2 T. Rowe Price New Horizons 2.44M 4.17% ▼ 0.05% Jul 31, 2026
3 Eventide Healthcare & Life Sciences I 1.37M 2.33% ▲ 0.00% Jun 30, 2026
4 T. Rowe Price New Horizons Tr-A 1.08M 1.84% ▼ 13.71% Jun 30, 2026
5 Fidelity Select Health Care 999.77K 1.71% ▲ 9.28% Jul 31, 2026
6 Fidelity Select Medical Tech and Devcs 999.03K 1.70% ▲ 4.28% Jul 31, 2026
7 Franklin US Small Cap Growth Equity 966.63K 1.65% ▲ 22.04% Jul 31, 2026
8 Vanguard MStar Total Stk Mkt Idx Invest 927.19K 1.58% ▲ 0.00% Jul 31, 2026
9 Franklin Small Cap Growth Adv 858.41K 1.46% ▲ 8.37% Jul 31, 2026
10 iShares Russell 2000 ETF 682.75K 1.17% ▼ 0.56% Aug 31, 2026

Financial Highlights

Market Cap: $1.41B
EBITDA: $-126.03M
Book Value: $4.45
Earnings/Share: $-2.28
Profit Margin: -138.35%
Operating Margin: -137.38%
ROA (TTM): -25.75%
ROE (TTM): -56.60%
Revenue (TTM): $95.13M
Revenue/Share (TTM): $1.76
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 66.20%

Valuation Metrics

Enterprise Value: $1.36B
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 58.60M
Shares Float: 32.78M
% Insiders: 5.30%
% Institutions: 103.20%
Short % Float: 9.69%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$95.13M
Cost of Goods Sold
adjust
$-46.26M
Gross Profit
subtotal
$48.86M
SG&A
adjust
$-164.12M
R&D
adjust
$-19.48M
Operating Income
subtotal
$-134.74M
Other / Non-Operating Items
adjust
$3.13M
Net Income
subtotal
$-131.61M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KMTS.US!